Cargando…

Side Effects, Self-Management Activities, and Adherence to Oral Anticancer Agents

PURPOSE: There are growing concerns about patients’ adherence to oral anticancer agents (OAAs), and the need for patients to engage in self-management of OAA-related side effects. We assessed associations among adherence, severity of side effects, and effectiveness of self-management of side effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yun, Wickersham, Karen E, Zhang, Xingyu, Barton, Debra L, Farris, Karen B, Krauss, John C, Harris, Marcelline R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997414/ https://www.ncbi.nlm.nih.gov/pubmed/32099335 http://dx.doi.org/10.2147/PPA.S224496

Ejemplares similares

Tolerance to oral anticancer agent treatment in older adults with cancer: a secondary analysis of data from electronic health records and a pilot study of patient-reported outcomes
por: Jiang, Yun, et al.
Publicado: (2022)

Oral anticancer agent medication adherence by outpatients
por: KIMURA, MICHIO, et al.
Publicado: (2014)

Implementation of a model integrating primary and oncology pharmacists' care for patients taking oral anticancer agents (OAA)
por: Farris, Karen B., et al.
Publicado: (2022)

Technologies for Medication Adherence Monitoring and Technology Assessment Criteria: Narrative Review
por: Mason, Madilyn, et al.
Publicado: (2022)

The Potential Impact of Intelligent Systems for Mobile Health Self-Management Support: Monte Carlo Simulations of Text Message Support for Medication Adherence
por: Piette, John D., et al.
Publicado: (2014)

“Keeping the Boogie Man Away”: Medication Self-Management among Women Receiving Anastrozole Therapy
por: Wickersham, Karen, et al.
Publicado: (2012)

Provider‐ and patient‐level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma
por: Spees, Lisa P., et al.
Publicado: (2021)

Adherence to Oral Hypoglycemic Agents in Hawaii
por: Lee, Rachel, et al.
Publicado: (2005)

Barriers and facilitators associated with implementing interventions to support oral anticancer agent adherence in academic and community cancer center settings
por: Muluneh, Benyam, et al.
Publicado: (2023)

Patient satisfaction with information on oral anticancer agent use
por: Boons, Christel C. L. M., et al.
Publicado: (2017)

Acceptance and Use of Home-Based Electronic Symptom Self-Reporting Systems in Patients With Cancer: Systematic Review
por: Cho, Youmin, et al.
Publicado: (2021)

Supporting adherence to oral anticancer agents: clinical practice and clues to improve care provided by physicians, nurse practitioners, nurses and pharmacists
por: Timmers, Lonneke, et al.
Publicado: (2017)

Multiple Adherence Tool Evaluation Study (MATES)
por: Witry, Matthew J., et al.
Publicado: (2014)

Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer()
por: Harada, Koji, et al.
Publicado: (2017)

In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer Agent
por: Olszewski, Ulrike, et al.
Publicado: (2009)

Change in Medication Adherence and Beliefs in Medicines Over Time in Older Adults
por: Unni, Elizabeth J, et al.
Publicado: (2016)

Adherence to Oral Anticancer Medications: Evolving Interprofessional Roles and Pharmacist Workforce Considerations
por: Paolella, Gennaro A., et al.
Publicado: (2018)

A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments
por: Schneider, Marie Paule, et al.
Publicado: (2019)

Self-Assembled Alkylated Polyamine Analogs as Supramolecular Anticancer Agents
por: Sil, Diptesh, et al.
Publicado: (2022)

The Effect of Structured Education to Patients Receiving Oral Agents for Cancer Treatment on Medication Adherence and Self-efficacy
por: Tokdemir, Gamze, et al.
Publicado: (2017)

Managing Drug Interactions With Oral Anticancer Treatments
por: Lohr, Lisa K., et al.
Publicado: (2023)

Investigation of Intervention Solutions to Enhance Adherence to Oral Anticancer Medicines in Adults: Overview of Reviews
por: Dang, Thu Ha, et al.
Publicado: (2022)

Predictors of adherence to oral anticancer medications: An analysis of 2010-2018 US nationwide claims
por: Vyas, Ami, et al.
Publicado: (2022)

Flavonoids as Anticancer Agents
por: Kopustinskiene, Dalia M., et al.
Publicado: (2020)

Anticancer agents : frontiers in cancer chemotherapy /
Publicado: (2001)

Inner conflict in patients receiving oral anticancer agents: a qualitative study
por: Yagasaki, Kaori, et al.
Publicado: (2015)

Video reflexive ethnography as an intervention to improve oral anti-cancer agent patient education: A pilot study
por: Manojlovich, Milisa, et al.
Publicado: (2023)

Why individual‐level interventions are not enough: Systems‐level determinants of oral anticancer medication adherence
por: Dean, Lorraine T., et al.
Publicado: (2020)

Assessment of Oral Anticancer Medication Adherence: A Survey from a Tertiary Cancer Center
por: Ramachandiran, Balaji, et al.
Publicado: (2021)

Adherence to Oral Anticancer Medications Among Women With Breast Cancer in Africa: A Scoping Review
por: Onwusah, Deborah O., et al.
Publicado: (2023)

Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods
por: Bourmaud, Aurélie, et al.
Publicado: (2015)

Cognition and drug adherence to oral hypoglycemic and antihypertensive agents in older adults
por: Bakouni, Hamzah, et al.
Publicado: (2019)

Advances in Oral Oncolytic Agents for Breast Cancer and Recommendations for Promoting Adherence
por: Gillespie, Theresa Wicklin
Publicado: (2020)

Advances in Oral Oncolytic Agents for Breast Cancer and Recommendations for Promoting Adherence
Publicado: (2020)

278 Developing AMILDA: An Intervention to Improve Symptoms and Medication Adherence among Latinx Adults with Depression and Anxiety
por: Mitrzyk, Beatriz Manzor, et al.
Publicado: (2022)

Poly(l-Ornithine)-Based Polymeric Micelles as pH-Responsive Macromolecular Anticancer Agents
por: Pan, Miao, et al.
Publicado: (2023)

Astragaloside IV, as a potential anticancer agent
por: Xia, Dongqin, et al.
Publicado: (2023)

Mistletoe treatments for minimising side effects of anticancer chemotherapy
por: Lange-Lindberg, Anna-Maria, et al.
Publicado: (2006)

ER maleate is a novel anticancer agent in oral cancer: implications for cancer therapy
por: Fu, Guodong, et al.
Publicado: (2016)

Radiation Recall with Anticancer Agents
por: Burris, Howard A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9ef5ih80ut6vcbki1s43q5tpi2